Side effects and safety considerations Tirzepatide produces side effects in most patients, though severity and specific symptoms vary widely
GLP-1 RAs, widely prescribed for T2DM and obesity, are increasingly used by women of reproductive age
Yes, as long as you are healthy and qualify for the program, oral tirzepatide is safe for any patient
Does rotating injection sites change how well the medication works
Canadian approval of semaglutide copy could lower GLP1 costs for plan sponsors Canada could see one of the first generic versions of Ozempic on the market as early as this year, potentially reshaping access to GLP1 drugs
D., Brighenti, F., & Porrini, M